First floor

Annex 10

Photo of Redazione Fedaiisf Fedaisf editorial staffMarch 7, 2020
995 Meno di un minuto

Allegato 10 n.1 Malattia di Kawasaki

Allegato 10 n.2 linee-guida-m-kawasaki-small (1)

Allegato 10 n.3 Malattia-di-Kawasaki aggiornamenti terapia

Allegato 10 n.4 Raccomandazioni AAC per m. di Kawasaki

Photo of Redazione Fedaiisf Fedaisf editorial staffMarch 7, 2020
995 Meno di un minuto
Photo of Redazione Fedaiisf

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Italy, R&D: top managers earn as much as an employee in a lifetime in one year

July 29, 2014

In Puglia nel 2023 sforata la spesa farmaceutica. I DG delle ASL dovrebbero decadere

9 April 2024

Intercepted for alleged harassment, bribes emerge: chief physician of Chieti arrested

July 14, 2014

Pfizer, Pharma increasingly Big the obligatory path to growth

May 12, 2014
Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco